SANOFI INDIA Financial Statement Analysis
|
||
|
The Revenues of SANOFI INDIA have increased by 2.92% YoY .
The Earnings Per Share (EPS) of SANOFI INDIA has decreased by -2.81 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SANOFI INDIA Last 5 Annual Financial Results
[BOM: 500674|NSE : SANOFI]
| Standalone | Dec2023 | Dec2022 | Dec2021 | Dec2020 | Dec2019 |
|---|---|---|---|---|---|
| Revenues | ₹2,851 Cr | ₹2,770 Cr | ₹2,957 Cr | ₹2,902 Cr | ₹3,071 Cr |
| Expenses | ₹2,048 Cr | ₹2,067 Cr | ₹2,194 Cr | ₹2,189 Cr | ₹2,405 Cr |
| Operating Profit (Excl OI) | ₹803 Cr | ₹703 Cr | ₹762 Cr | ₹713 Cr | ₹665 Cr |
| Other Income | ₹67 Cr | ₹73 Cr | ₹75 Cr | ₹90 Cr | ₹94 Cr |
| Interest | ₹1.70 Cr | ₹1.70 Cr | ₹1.80 Cr | ₹1.80 Cr | ₹0.30 Cr |
| Depreciation | ₹40 Cr | ₹42 Cr | ₹67 Cr | ₹82 Cr | ₹100 Cr |
| Profit Before Tax | ₹846 Cr | ₹864 Cr | ₹1,258 Cr | ₹677 Cr | ₹600 Cr |
| Profit After Tax | ₹603 Cr | ₹621 Cr | ₹944 Cr | ₹478 Cr | ₹414 Cr |
| Consolidated Net Profit | ₹603 Cr | ₹621 Cr | ₹944 Cr | ₹478 Cr | ₹414 Cr |
| Earnings Per Share (Rs) | ₹262.26 | ₹269.83 | ₹410.61 | ₹207.65 | ₹180.09 |
| PAT Margin (%) | 20.35 | 21.27 | 31.94 | 16.46 | 12.91 |
| ROE(%) | 55.83 | 36.73 | 44.65 | 21.39 | 18.07 |
| ROCE(%) | 73.98 | 49.47 | 57.98 | 29.77 | 25.75 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 14,142.6 Cr |
| Revenue (TTM) | : | ₹ 2,413.8 Cr |
| Net Profit(TTM) | : | ₹ 424.7 Cr |
| EPS (TTM) | : | ₹ 184.7 |
| P/E (TTM) | : | 33.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SANOFI INDIA | -4% | -9.1% | -20.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | -7.1% | 48% |
| CIPLA | -3.5% | -5.2% | 18% |
| DR REDDYS LABORATORIES | -3.9% | -10.1% | 10.1% |
| ZYDUS LIFESCIENCES | -0.3% | -7.3% | 52.2% |
| DIVIS LABORATORIES | 1.5% | -2.1% | 63% |
| MANKIND PHARMA | -2.3% | -3% | 39.6% |
| TORRENT PHARMACEUTICALS | -1.8% | -10.2% | 51.3% |
| LUPIN | -2.4% | -6.4% | 73.9% |
SANOFI INDIA Revenues
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | 2.92 % |
| 5 Yr CAGR | -1.84 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Dec2023 | ₹2,851 Cr | 2.92 | |
| Dec2022 | ₹2,770 Cr | -6.31 | |
| Dec2021 | ₹2,957 Cr | 1.88 | |
| Dec2020 | ₹2,902 Cr | -5.49 | |
| Dec2019 | ₹3,071 Cr | - | |
SANOFI INDIA Operating Profit
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | 14.21 % |
| 5 Yr CAGR | 4.81 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Dec2023 | ₹803 Cr | 14.21 | |
| Dec2022 | ₹703 Cr | -7.79 | |
| Dec2021 | ₹762 Cr | 6.90 | |
| Dec2020 | ₹713 Cr | 7.18 | |
| Dec2019 | ₹665 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 11.00 % |
| 5 Yr CAGR | 6.77 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2023 | 28.16% | 11.00 | |
| Dec2022 | 25.37% | -1.59 | |
| Dec2021 | 25.78% | 4.92 | |
| Dec2020 | 24.57% | 13.38 | |
| Dec2019 | 21.67% | - | |
SANOFI INDIA Profit After Tax
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -2.80 % |
| 5 Yr CAGR | 9.85 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2023 | ₹603 Cr | -2.80 | |
| Dec2022 | ₹621 Cr | -34.29 | |
| Dec2021 | ₹944 Cr | 97.74 | |
| Dec2020 | ₹478 Cr | 15.31 | |
| Dec2019 | ₹414 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -4.33 % |
| 5 Yr CAGR | 12.05 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2023 | 20.35 % | -4.33 | |
| Dec2022 | 21.27 % | -33.41 | |
| Dec2021 | 31.94 % | 94.05 | |
| Dec2020 | 16.46 % | 27.50 | |
| Dec2019 | 12.91 % | - | |
SANOFI INDIA Earnings Per Share (EPS)
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -2.81 % |
| 5 Yr CAGR | 9.85 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Dec2023 | ₹262 | -2.81 | |
| Dec2022 | ₹270 | -34.29 | |
| Dec2021 | ₹411 | 97.74 | |
| Dec2020 | ₹208 | 15.30 | |
| Dec2019 | ₹180 | - | |
SANOFI INDIA Return on Capital Employed (ROCE)
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | 49.55 % |
| 5 Yr CAGR | 30.19 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Dec2023 | 73.98% | 49.55 | |
| Dec2022 | 49.47% | -14.68 | |
| Dec2021 | 57.98% | 94.76 | |
| Dec2020 | 29.77% | 15.61 | |
| Dec2019 | 25.75% | - | |
SANOFI INDIA Share Price vs Sensex
| Current Share Price | : | ₹6,149.0 |
| Current MarketCap | : | ₹ 14,142.6 Cr |
| Updated EOD on | : | Nov 19,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANOFI INDIA | -4% |
-9.1% |
-20.8% |
| SENSEX | -2.4% |
-4.2% |
19.5% |
SANOFI INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE HEALTHCARE | -2.5% | -4% | 46.8% |
| S&P BSE MIDSMALLCAP | -2.9% | -7% | 35.6% |
| S&P BSE SMALL CAP | -3.3% | -7.2% | 35.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 | -2.6% | -5.9% | 27.1% |
| NIFTY500 MULTICAP 50:25:25 | -2.7% | -6.3% | 28.8% |
| NIFTY MID SMALL400 | -2.7% | -7.1% | 32.4% |
| NIFTY SMALLCAP250 | -3.3% | -7.7% | 32.3% |
You may also like the below Video Courses
FAQ about SANOFI INDIA Financials
How the annual revenues of SANOFI INDIA have changed ?
The Revenues of SANOFI INDIA have increased by 2.92% YoY .
How the Earnings per Share (EPS) of SANOFI INDIA have changed?
The Earnings Per Share (EPS) of SANOFI INDIA has decreased by -2.81 % YoY .
Check out Intrinsic Value of Peers of SANOFI INDIA
Compare Stock Analytics of Peers of SANOFI INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
